Often described as the next frontier in gene therapy, siRNA has moved from the realm of the quirky biological oddity to applied therapy very quickly. I have asked the Tox1401 students to describe what they see as potential toxicological problems with this approach.
We used this paper as a description of the possible delivery approaches. The paper is freely (and fully) available from pubmed central.
Read on through the comments to see what they came up with.